Dermatology · Edenton, NC
NPI
1417966409
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
222 Virginia Rd
Edenton, NC, 27932
Phone (252) 752-4124
Groups this clinician bills Medicare through
Medicare paid, 2024
$488K
18,486 services
Medicare patients, 2024
1,720
Average age 77
Drug cost, 2024
$2.2M
2,347 prescriptions
Company payments, 2025
$217
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mathijs H Brentjens was code 17003 (destruction skin lesion), 9,867 times for 1,110 patients. In total Mathijs H Brentjens billed 18,486 services in 56 codes, and Medicare paid $488K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-04-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 9,867 | 1,110 | $4.49 | $44K |
| 99213 Office E&M - Established | Office | 3,270 | 1,587 | $56.80 | $186K |
| 17000 Destruction Skin Lesion | Office | 2,419 | 1,314 | $35.50 | $86K |
| 11102 Skin Biopsy | Office | 624 | 502 | $60.88 | $38K |
| 17110 Destruction Skin Lesion | Office | 599 | 490 | $75.09 | $45K |
| 96900 Skin | Office | 318 | 13 | $17.64 | $5,610 |
| 17004 Destruction Skin Lesion | Office | 212 | 141 | $110.53 | $23K |
| 99203 Office E&M - New | Office | 170 | 170 | $60.58 | $10K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 100 | 34 | $0.62 | $61.69 |
| 99212 Office E&M - Established | Office | 72 | 60 | $38.81 | $2,794 |
| 11103 Skin Biopsy | Office | 70 | 60 | $36.25 | $2,537 |
| 36415 Venipuncture Blood Collection | Office | 70 | 25 | $8.65 | $606 |
| 17261 Destruction Skin Lesion | Office | 50 | 46 | $88.00 | $4,400 |
| 11900 Skin | Office | 42 | 27 | $20.51 | $862 |
| 17262 Destruction Skin Lesion | Office | 37 | 36 | $124.05 | $4,590 |
By year: 2022 $476K for 17,385 services; 2023 $480K for 17,557 services; 2024 $488K for 18,486 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 70 | 25 | $8.65 | $606 |
| Q0112 All potassium hydroxide (koh) preparations | 31 | 30 | $5.71 | $177 |
Medicare prescription drug claims, 2024
In 2024, the drug Mathijs H Brentjens prescribed most often to Medicare patients was Triamcinolone Acetonide, with 348 prescriptions and refills. In total Mathijs H Brentjens wrote 2,347 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 348 | 368 | 226 | $4,457 |
| Clobetasol Propionate Generic | 343 | 354 | 189 | $15K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 201 | 215 | 101 | $5,618 |
| Ketoconazole Generic | 183 | 195 | 114 | $4,656 |
| Alclometasone Dipropionate Generic | 155 | 165 | 114 | $8,081 |
| Doxycycline Hyclate Generic | 126 | 168 | 57 | $1,544 |
| Fluocinonide Generic | 90 | 97 | 76 | $4,118 |
| Fluticasone Propionate Generic | 82 | 83 | 63 | $1,801 |
| Humira(Cf) Pen Adalimumab | 74 | 74 | Under 11 | $813K |
| Mupirocin Generic | 61 | 69 | 38 | $550 |
| Prednisone Generic | 56 | 58 | 22 | $250 |
| Hydroxyzine Hcl Generic | 50 | 68 | 14 | $415 |
| Fluorouracil Generic | 41 | 41 | 35 | $2,650 |
| Skyrizi Pen Risankizumab-Rzaa | 36 | 95 | Under 11 | $790K |
| Minoxidil Generic | 35 | 82 | 13 | $223 |
Brand drugs: 218 claims; generic drugs: 2,129 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mathijs H Brentjens $217 ($217 in general payments such as food, travel and fees) from 5 companies. The largest payer was Janssen Biotech, Inc. with $66.99.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.